• 検索結果がありません。

東北大学機関リポジトリTOUR

N/A
N/A
Protected

Academic year: 2021

シェア "東北大学機関リポジトリTOUR"

Copied!
61
0
0

読み込み中.... (全文を見る)

全文

(1)

Special Lecture 1 : The finding, development and progress of potassium channel openers

著者 柳澤 輝行

(2)

The finding, development and progress of

potassium channel openers.

Teruyuki YANAGISAWA, MD, PhD

Dept. Mol. Pharmacol.,

Tohoku Univ. Sch. Grad. Med.

The 87

th

Annual Meeting of The

Japanese Pharmacological Society

Sendai, 20140319, 10:45-11:45

(3)

The author has no conflict of interest

to disclose with respect to this

(4)

The development of nicorandil (SG-75)

The development of nicorandil (SG-75) was started under

the concept “a nitrate-like antianginal drug without

hypotensive side effect”. During the studies to explore the

mechanism of action of nicorandil, it has been revealed that

nicorandil opens potassium (K

+

) channel and that

ATP-sensitive K

+

channels (K

ATP

) are the target molecules, which

are also opened by other K

+

channel openers (KCO) as

antihypertensives. Although the clinical results related with

pure KCOs for hypertension have been failed, nicorandil

which is a hybrid of nitrate and KCO has been successful as a

drug for angina pectoris, acute myocardial infarction and

acute heart failure. We have also suggested that nicorandil

will be effective in managing pulmonary arterial

hypertension. The KCOs targeting other than K

ATP

are

expected to be novel therapeutic agents to control pain or

epilepsy, including many pathological situations.

(5)

K

+

channel openers (K

ATP

COs)

Historical points of view

Why they are not successful for the

antihypertensive agents?

Vasospastic angina

Hyperpolarization-relaxation coupling

Progress of new types KCOs

(6)

minoxidil, LP 805 Pyrimidine: O N N N H 2 H2N N trichogen Benzopyran: Cromakalim O H N C O C H 3 C H 3 N O * *

K

+

channel openers

Pyridine:

nicorandil

KRN2391 C O N H C H 2C H 2O N O 2 N "N-K hybrid" NO, cGMP ↑ Hyperglycemia (side effect) Insulin secretion↓ KATP open in β cell

3 N NH S O Cl CH 2 Benzothiadiazine: diazoxide "Nonspecific KCO" Hypertricosis as a side effect

cf. ischemic preconditioning;

pharmacological

(7)

The development of nicorandil (SG-75)

Blood-perfused cardiac preparations in

Tohoku University

The serendipity to find K

+

opening activity

(8)

Dr. Sakai, K

(Born in Ishinomaki)

(9)

The Development of nicorandil

(10)

Blood

pressure

(mmHg)

Coronary

blood flow

(ml/min)

Heart rate

(beats/min)

Nicorandil

Modified from i. v.: intravenous injection

(11)

Nicorandil

(SG-75):

coronary resistance↓

Intraduodenal administration of nicorandil (3mg/kg) ≒ intravenous injection (0.3mg/kg)

Taira N, Satoh K, Yanagisawa T et al. Clin Exp Pharmacol Physiol 1979;6:301-16. SEM in parentheses, n=5. : P<0.05,

(12)

Nicorandil

(SG-75):

coronary resistance↓

Intraduodenal administration of nicorandil (3mg/kg)

≒ intravenous injection (0.3mg/kg)

Taira N, Satoh K, Yanagisawa T et al. Clin Exp Pharmacol Physiol 1979;6:301-16. SEM in parentheses, n=5. : P<0.05,

a.v.: arterio-venous; AV: atrioventricular

(13)

Distribution of cardiac output & O

2

consumption

in organs at rest

Organs Blood flow (mL/min) O2 consumption

(/100g) (Whole) (%) Brain Heart Liver Kidney Sk. muscle Skin Others Total (mL/min) (%)

In heart, the tissue O

2

partition pressure is low,

thus the organ is under relatively hypoxic condition.

K

ATP

channels are seemed to be easily opened in heart.

(14)

Isolated blood-perfused cardiac preparations

(15)

Increase in coronary blood flow,

Very llittle effect on sinoatrial (SA) rate

RA

RV

IVC

SVC SA node

Constant perfusion pressure

Injection, i. a.

SG-75

Nicorandil

(16)

Conduction system

AV node

; PSA: posterior septal artery←circumflexus artery

Ventricle

; ASA: anterior septal artery←left coronary artery

SA node AV node Bundle branch His B. Purkinje f. Slow response Ca2+ channel

Vent. Septum

(17)

N-Sch. Arch. Pharmacol. 1975:290:107-12.

Nifedipine vs. nicorandil on AV conduction time

(18)

No effect on AV conduction, furthermore

(19)
(20)
(21)

Arterial blood

Extra. potential

Force of contraction

Blood-perfused papillary muscle Fc Extra. potential Nicorandil

Nicorandil 1mg, i.a.

(22)

Acute ischemia causes a so-called

current of injury????

The concept of

K

ATP

channel opening

in ischemic/hypoxic cells.

The effect of on APD of cardiac muscle.

Ischemia-induced arrhythmia)

(Intra-arterial nicorandil-induced V.F.)

(23)

Acute ischemia causes a current of injury

Effort angina predominant subendocardial ischemia

ischemia involving the outer ventricular layer (transmural or epicardial injury)

(24)

Lead V4

at rest

(top) and after 4.5 min of

exercise

(bottom).

There is 0.3 mV of

horizontal ST-segment depression

,

indicating a positive test for ischemia.

1 mV 1 sec P Q R S T

(25)

Electrode

Acute ischemia causes ST changes

KATP opened Subendocardium

Epicardium

Conduction

(26)

http://ir.library.tohoku.ac.jp/re/bitstream/10097/40205/1/ YANAGISAWA-Teruyuki-01-09-0012.pdf

Ischemic arrhythmias in the light of K

ATP

Reentry

→VT, VF

(27)

SG-75-induced VT & VF in experiments with

blood-perfused canine preparations

We have given clinicians the caution of the risk of

intracoronary administration of nicorandil.

Fortunately, there has been no report related

accidents

(28)

(Am J Cardiol 1989;63:18J-24J)

Cromakalim and pinacidil, nonnitrate KCO, have

essentially the same cardiovascular profile as nicorandil in

isolated, blood-perfused canine heart preparations.

1) The property of nicorandil as a resistive vessel dilator highly

selective for vasculature originates in its mechanism of action as a K-channel activator.

2) The non-unanimous effect of nicorandil on venous return is a result of the opposing actions as a capacitive (action as a nitrate) and a

resistive vessel dilator.

3) Nicorandil, with its hybrid nature, is advantageous over specific K-channel activators and classic nitrates in therapeutic implications.

(29)

Selectivity spectra for coronary blood flow vs. cardiac variables

Am J Cardiol. 1987;59(3):24B-29B

(30)

Canine atrial muscle comparison with ACh

(31)

Canine atrial muscle comparison with ACh

(32)

SG-75 increases P

K

(33)

Effect of SG-75 on membrane potentials of a

spontaneously firing canine Purkinje fiber

10

-6

M SG-75

10

-5

M SG-75

10

-4

M SG-75

Control

(34)

Slow response in 27 mM K

+

20 msec

20 mV

Hyperpolarization

Shorten APD

(35)

【Conclusion-1】

Findings in blood-perfused cardiac prep.

SG-75 increases coronary blood flow.

No effect on AV conduction

Induction of ventricular fibrillation in high dose

Shorten QT interval

Shorten APD of ventricular muscle

The mechanism is not Ca

2+

channel blockade.

(36)

K

+

channel openers (K

ATP

COs)

Historical points of view

Why they are not successful for the

antihypertensive agents?

Vasospastic angina

Hyperpolarization-relaxation coupling

Progress of new types KCOs

(37)
(38)

Treatment of

vasospastic angina

(39)
(40)

Vm(mV) -55 -90 K+ channel Ca2+ channel Vascular sm.m.tone Vascular diameter K+ channel opener hyperpolarization -75 -40 rested Ca2+ depolarization K+ open Hyperpolarization-relaxation coupling K+ K+ K + K+ K+ Ca2+ Ca2+Ca2+Ca2+ Ca2+ close close open

Hypertension, spasm, agonists

(41)

Dissociation of

[Ca

2+

]

i

& Force of contraction

(42)

Repolarization

vs.

Inhibition of Ca influx

(43)
(44)

-10mV

-34mV -47mV

-55mV

-42mV -38mV -24mV -30mV

[Ca

2+

]

i

-Fc relation;

Vm

(45)

Repolarization & Ca sensitivity

Membrane potential (mV)

C

hange

s i

n

C

a

sens

iti

vi

ty

(%

)

90K-2.5Ca 5K-2.5Ca

(46)

RhoK distribution

(47)
(48)

Relationship

between [Ca

2+

]

i

and force of

contraction

induced by

serotonin ( 10

-6.5

M) in the absence

(

) and presence

of levcromakalim

( 10

-5.5

M,

) or

nicardipine (

).

-60 -40 -20 0 20 40 60 80 0 10 20 30 40 50 60 70 80 90

[Ca

2+

]

i

(%)

c

-10 100

F

o

rce (

%)

0 0.1 0.3 1.0 2.5 10 0 0.1 0.3 1.0 2.5 10 *** 10-6.5 M 10-5.5 M

Ca sensitivity

by a KCO

(49)

C

o n t r o l

F

u r a - 2

r

a t i o

0

. 6

0

. 5

F

o r c e

(

m N )

0

3

1 0 m i n

U

4 6 6 1 9

C

a f f e i n e

C

r

o

m

a

k

a

l

i

m

1

0

-5

M

0

C a

Naunyn-Schmied. Arch. Pharmacol. 1992;346:691-700. Biochem. Biophys. Res. Commun. 1992;187:1517-22. K+ channel opener inhibits IP

3 generation & Ca2+ release from SR by

(50)

Activation of phospholipase C by the agonist U46619 is inhibited by cromakalim-induced hyperpolarization in porcine coronary artery. (in the absence of [Ca2+]

o)

(51)

Hyperpolarization

Molecular signal mechanisms of

relaxation

of

vascular smooth muscle via Hyperpolarization

Hyperpolarization

Hyperpolarization

Hyperpolarization

K

ATP

K

ca

K

ir

(52)

Nicorandil, Nitroglycerin

NO→cGMP→G kinase

Hyperpolarization decreases Ca sensitivity

Hyperpolarization Hyperpolarization

K

ATP

K

ca

K

ir

KCO

Nicorandil

Nitroglycerin

EDHF

Circulation 2011;124:1774-82 (modified)

as NK hybrid

(53)

In the presence of nitroglycerin,

Dissociation of

[Ca

2+

]

i

& Fc

Ca

2+

desensitization

Yanagisawa T. Br J Pharmacol 1989; 98: 469

Ca

2+

sensitization

(54)

Pathogenic mechanisms in coronary artery spasm.

Circulation 2011;124:1774-82

Hyperpolarization:

(55)

【Conclusion-2】

Coronary artery spasm mechanisms.

Ca

2+

sensitivity in vasc. sm. m. is

increased

or

decreased

by

depolarization

or

hyperpolarization

,

respectively.

The concept of hyperpolarization-relaxation

coupling via. KCO or EDHF is very important,

since we have precisely known the molecular

mechanisms of vasospasm.

(56)

K

+

channel openers (K

ATP

COs)

Historical points of view

Why they are not successful for the

antihypertensive agents?

Vasospastic angina

Hyperpolarization-relaxation coupling

(57)

【Appendix】

The future of K

ATP

COs & other type of KCOs

Organ perfusion preservation of organ transplant

Pulmonary arterial hypertension; Sahara M et al.

PLoS One. 2012;7(3):e33367. doi: 10.1371/

journal.pone.0033367.

Advanced diabetic nephropathy; Tanabe K et al.

Am J Physiol Renal Physiol. 2012;302:F1151-60.

(58)

KATP BKCa, IKCa Kv ~100 pS, ~10 pS ~10 pS ~100 pS, ~60 pS -90 -80 -70 -60 -50

Vm

(mV)

100 80 60 40 20 0 150 pS 10 pS 20 pS 40 pS 60 pS 100 pS

Single channel conductance

Open channel number in vascular sm. m. cell E K =

Folia Pharmacol. Jpn. 1995;106:157-69.

(59)
(60)

Anticonvulsant, Analgesic

Ezogabine (Retigabine ): KCNQ/Kv7 opener,

anticonvulsant.

Flupirtine: the same mechanism , non-opioid

analgesic, muscle relaxant and anticonvulsant.

(61)

Thank you for your attention!

参照

関連したドキュメント

Making use, from the preceding paper, of the affirmative solution of the Spectral Conjecture, it is shown here that the general boundaries, of the minimal Gerschgorin sets for

We show that a discrete fixed point theorem of Eilenberg is equivalent to the restriction of the contraction principle to the class of non-Archimedean bounded metric spaces.. We

In particular, we show that the q-heat polynomials and the q-associated functions are closely related to the discrete q-Hermite I polynomials and the discrete q-Hermite II

The oscillations of the diffusion coefficient along the edges of a metric graph induce internal singularities in the global system which, together with the high complexity of

Then it follows immediately from a suitable version of “Hensel’s Lemma” [cf., e.g., the argument of [4], Lemma 2.1] that S may be obtained, as the notation suggests, as the m A

So far, most spectral and analytic properties mirror of M Z 0 those of periodic Schr¨odinger operators, but there are two important differences: (i) M 0 is not bounded from below

Our situation is different from the cases studied in [19] or [20], where they have considered the energy J with a ≡ 1 in a multiply connected domain without applied magnetic

One important application of the the- orem of Floyd and Oertel is the proof of a theorem of Hatcher [15], which says that incompressible surfaces in an orientable and